p27 expression correlates with short-term, but not with long-term prognosis in breast cancer

Breast Cancer Research and Treatment

Volumn 67, Issue 1, 2001, Pages 15-22

  Leivonen, M ^a   Nordling, S ^b   Lundin, J ^b   Von Boguslawski, K ^b   Haglund, C ^b  

^a PEIJAS HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Breast neoplasms; Immunohistochemistry; Prognosis

Indexed keywords

HORMONE RECEPTOR; PROTEIN P27;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CYCLIN-DEPENDENT KINASES; FEMALE; HUMANS; MICROFILAMENT PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; NEOPLASM PROTEINS; PROGNOSIS;

EID: 0034900641     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010623326118     Document Type: Article

References (25)

1. Inhibitors of mammalian G1 cyclin-dependent kinases
2. G1 control in mammalian cells
3. Interleukin-2-mediated elimination of p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
4. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle
5. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
6. Prognostic significance of p27(Kip1) expression in colorectal cancer: A clinico-pathological characterization
7. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small-cell lung cancer
8. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma
9. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma
10. Low p27 expression predicts poor disease-free survival in patients with prostate cancer
11. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primau breast cancer
12. High level expression of p27kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27kip1 and degree of malignancy in human breast and colorectal cancers
13. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas
14. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
15. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
16. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry
17. Analysis of PCP data to determine the fraction of cells in various phases of cell cycle
18. Role of the ubiquitin-proteosome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
19. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias
20. p27Kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors
21. p27/Kip1 mutation found in breast cancer
22. Cell cycle and cancer
23. Time-dependence of hazard ratios for prognostic factors in primary breast cancer
24. P27Kip1 expression in breast carcinomas: An immunohistochemical study on 512 patients with long-term follow-up